SEC delays decision on Bitwise ETF, extending review to March 2025 amid evaluation of new crypto investment products.
Pharmaceutical giant Johnson & Johnson (J&J) (NYSE:JNJ) has announced plans to acquire Intra-Cellular Therapies (NASDAQ:ITCI) ...
Investors looked ahead to the release of December’s CPI data and the start of the fourth-quarter earnings season.